London · Delayed Price · Currency is GBP · Price in GBX Oxford Nanopore Technologies Company Description
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA.
The company offers MinION Mk 1D, a portable device for DNA and RNA sequencing; and GridION and GridION Q, a compact bench top device that delivers a version of hardware, software, and chemistry.
It also provides PromethION products, such as PromethION 2, PromethION 24, and PromethION 48. The company has a collaboration with Cepheid to develop and commercialize automated infectious disease sequencing solutions.
It operates in the region of Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008.
Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom.
| Country | United Kingdom |
| Founded | 2005 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1,316 |
| CEO | Francis Albert Van Parys |
Contact Details
Address: Gosling Building Oxford, OX4 4DQ United Kingdom | |
| Phone | 44 80 8502 3445 |
| Website | nanoporetech.com |
Stock Details
| Ticker Symbol | ONT |
| Exchange | London Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | GBP |
| ISIN Number | GB00BP6S8Z30 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Nicholas Patrick Keher | Chief Financial Officer and Director |
| Lakmal Jayasinghe | Chief Scientific Officer |
| Jordan Herman | Senior Vice President and General Counsel |
| John Schoellerman | Senior Vice President of Corporate and Business Development |
| Richard Compton | Senior Vice President of Sales and Commercial Operations |
| Sarah Lapworth | Senior Vice President of Global Human Resources |
| Zoe McDougall | Senior Vice President of Strategic Communications and Corporate Affairs |
| Kathleen Barnes | Senior Vice President of Population Health and Precision Medicine |